Titan Medical (NASDAQ:TMDI) and Irhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability and dividends.
This table compares Titan Medical and Irhythm Technologies’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
This table compares Titan Medical and Irhythm Technologies’ gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Irhythm Technologies||$98.51 million||19.42||-$29.42 million||($1.30)||-61.44|
Titan Medical has higher earnings, but lower revenue than Irhythm Technologies.
This is a breakdown of recent ratings and target prices for Titan Medical and Irhythm Technologies, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Titan Medical currently has a consensus target price of $6.67, suggesting a potential upside of 230.03%. Irhythm Technologies has a consensus target price of $94.14, suggesting a potential upside of 17.87%. Given Titan Medical’s stronger consensus rating and higher probable upside, research analysts clearly believe Titan Medical is more favorable than Irhythm Technologies.
Insider and Institutional Ownership
0.5% of Titan Medical shares are held by institutional investors. 23.3% of Irhythm Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Titan Medical beats Irhythm Technologies on 6 of the 9 factors compared between the two stocks.
About Titan Medical
Titan Medical Inc., a development stage company, focuses on design and development of robotic surgical system for application in minimally invasive surgery (MIS). The company is developing SPORT Surgical System, a single-port robotic surgical system that comprises a surgeon-controlled patient cart, which includes a 3D vision system and multi-articulating instruments for performing MIS procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during MIS procedures. The SPORT Surgical System enables surgeons to perform various surgical procedures for general abdominal, gynecologic, urologic, and colorectal indications. The company is headquartered in Toronto, Canada.
About Irhythm Technologies
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. The company offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. Its Zio XT monitor, a single-use, wire-free, and wearable patch-based biosensor, records patient's heartbeats and ECG data. The company was founded in 2006 and is headquartered in San Francisco, California.
Receive News & Ratings for Titan Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Titan Medical and related companies with MarketBeat.com's FREE daily email newsletter.